aTYR PHARMA INC Marketable Securities (Current)
aTYR PHARMA INC (ATYR) had Marketable Securities (Current) of $0 as of 2015-03-31, per its 10-Q filed 2015-06-18.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecuritiesCurrent · last filed 2015-06-18
- 2015-03-31: Marketable Securities, Current $0.00.
- 2014-12-31: Marketable Securities, Current $1.95M.
| Period end | Marketable Securities, Current |
|---|---|
| 2015-03-31 | $0.00 10-Q · filed 2015-06-18 |
| 2014-12-31 | $1.95M 10-Q · filed 2015-06-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |